Statistics
Publications
25
Citations
1.8K
H-Index
20
Active since
1986
Affiliations
Mark A. Matulenko is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
1986–2023
25
25
Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 523 citations · Full text
Medicine, Neurobiology, Pharmacology +17
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text
Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations
1–5 of 25